These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29735188)

  • 1. Will There Be a Clinically Significant Role for Protons in Patients With Gastrointestinal Malignancies?
    Raldow AC; Hong TS
    Semin Radiat Oncol; 2018 Apr; 28(2):125-130. PubMed ID: 29735188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Therapy.
    LaRiviere MJ; Santos PMG; Hill-Kayser CE; Metz JM
    Hematol Oncol Clin North Am; 2019 Dec; 33(6):989-1009. PubMed ID: 31668216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?
    Liao Z; Gandhi SJ; Lin SH; Bradley J
    Semin Radiat Oncol; 2018 Apr; 28(2):114-124. PubMed ID: 29735187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Morbidity Reduction With Proton Radiation Therapy for Breast Cancer.
    Braunstein LZ; Cahlon O
    Semin Radiat Oncol; 2018 Apr; 28(2):138-149. PubMed ID: 29735190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical controversies: proton radiation therapy for brain and skull base tumors.
    Combs SE; Laperriere N; Brada M
    Semin Radiat Oncol; 2013 Apr; 23(2):120-6. PubMed ID: 23473689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma.
    Harrabi SB; Bougatf N; Mohr A; Haberer T; Herfarth K; Combs SE; Debus J; Adeberg S
    Strahlenther Onkol; 2016 Nov; 192(11):759-769. PubMed ID: 27363701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal cancer: nonliver proton therapy for gastrointestinal cancers.
    Plastaras JP; Dionisi F; Wo JY
    Cancer J; 2014; 20(6):378-86. PubMed ID: 25415682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.
    Flejmer AM; Edvardsson A; Dohlmar F; Josefsson D; Nilsson M; Witt Nyström P; Dasu A
    Acta Oncol; 2016 May; 55(5):577-83. PubMed ID: 27027913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical controversies: proton therapy for pediatric tumors.
    Merchant TE
    Semin Radiat Oncol; 2013 Apr; 23(2):97-108. PubMed ID: 23473686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
    Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
    Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of proton beam radiation therapy in gastrointestinal cancer.
    Ask A; Johansson B; Glimelius B
    Acta Oncol; 2005; 44(8):896-903. PubMed ID: 16332599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Radiotherapy Technologies in the Treatment of Gastrointestinal Malignancies.
    Dalwadi SM; Herman JM; Das P; Holliday EB
    Hematol Oncol Clin North Am; 2020 Feb; 34(1):29-43. PubMed ID: 31739949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam therapy for tumors of the upper abdomen.
    Raldow A; Lamb J; Hong T
    Br J Radiol; 2020 Mar; 93(1107):20190226. PubMed ID: 31430202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pencil beam scanning proton therapy vs rotational arc radiation therapy: A treatment planning comparison for postoperative oropharyngeal cancer.
    Apinorasethkul O; Kirk M; Teo K; Swisher-McClure S; Lukens JN; Lin A
    Med Dosim; 2017 Spring; 42(1):7-11. PubMed ID: 27839693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical controversies: proton therapy for thoracic tumors.
    De Ruysscher D; Chang JY
    Semin Radiat Oncol; 2013 Apr; 23(2):115-9. PubMed ID: 23473688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison between proton and photon beams in the moving gap region in cranio-spinal irradiation (CSI).
    Cheng CW; Das IJ; Srivastava SP; Zhao L; Wolanski M; Simmons J; Johnstone PA; Buchsbaum JC
    Acta Oncol; 2013 Apr; 52(3):553-60. PubMed ID: 22554342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Have we reached proton beam therapy dosimetric limitations? - A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer.
    Ding X; Li X; Qin A; Zhou J; Yan D; Stevens C; Krauss D; Kabolizdeh P
    Acta Oncol; 2018 Mar; 57(3):435-437. PubMed ID: 28774218
    [No Abstract]   [Full Text] [Related]  

  • 20. Immobilization considerations for proton radiation therapy.
    Wroe AJ; Bush DA; Slater JD
    Technol Cancer Res Treat; 2014 Jun; 13(3):217-26. PubMed ID: 24066953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.